Public Comment Regarding: FDA Policy on Use of Ozone-Depleting Substances in Medical ProductsDate: 6/17/2002
|
President's Budget
Management
Information &
Regulatory Affairs
Legislative Information
Agency Information
|
|
||||
Federal Register
| Jobs at OMB | FOIA | No FEAR | OMB Locator | USA.gov | Accessibility
| Privacy Policy
| Site Search
| Help
|